Similar Articles
821 Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients
822 Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
823 Usefulness of the MESH score in a European hepatocellular carcinoma cohort
824 Effect of NDC80 in human hepatocellular carcinoma
825 Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
826 Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
827 Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma
828 Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
829 Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
830 Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA